TRVI (STOCKS)
Trevi Therapeutics, Inc. Common Stock
$14.950000
+0.740000 (+5.21%)
Prev close: $14.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jennifer L. Good
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,082.14M
- Employees
- 33
- P/E (TTM)
- -45.32
- P/B (TTM)
- 10.60
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.09 | $-0.08 | -0.0120 | -15.38% |
|
Dec 2025 (Q4)
|
$-0.06 | $-0.10 | +0.0401 | +40.06% |
|
Sep 2025 (Q3)
|
$-0.08 | $-0.10 | +0.0203 | +20.24% |
|
Jun 2025 (Q2)
|
$-0.09 | $-0.10 | +0.0130 | +12.62% |
Financial Statements
| Assets | $179.61M |
| Current Assets | $176.12M |
| Prepaid Expenses | $2.22M |
| Other Current Assets | $173.91M |
| Noncurrent Assets | $3.49M |
| Fixed Assets | $265.00K |
| Other Non-current Assets | $3.22M |
| Liabilities | $7.48M |
| Current Liabilities | $7.12M |
| Accounts Payable | $2.22M |
| Other Current Liabilities | $4.90M |
| Noncurrent Liabilities | $364.00K |
| Equity | $172.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $172.13M |
| Liabilities And Equity | $179.61M |